KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 95 filers reported holding KRONOS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,977 | -98.3% | 1,521 | -97.8% | 0.00% | – |
| Q2 2023 | $116,905 | -97.1% | 67,968 | -97.5% | 0.00% | – |
| Q1 2023 | $4,003,000 | +96056.6% | 2,742,201 | +6.7% | 0.00% | -100.0% |
| Q4 2022 | $4,163 | -100.0% | 2,569,592 | +0.6% | 0.00% | 0.0% |
| Q3 2022 | $8,555,000 | -10.1% | 2,553,592 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $9,521,000 | -48.7% | 2,615,518 | +2.0% | 0.00% | -50.0% |
| Q1 2022 | $18,546,000 | -5.3% | 2,565,047 | +77.9% | 0.00% | 0.0% |
| Q4 2021 | $19,590,000 | -37.2% | 1,441,519 | -3.1% | 0.00% | -50.0% |
| Q3 2021 | $31,181,000 | -16.5% | 1,487,689 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $37,343,000 | -21.4% | 1,559,188 | -3.9% | 0.00% | -33.3% |
| Q1 2021 | $47,506,000 | -0.9% | 1,623,038 | +1.1% | 0.01% | -14.3% |
| Q4 2020 | $47,934,000 | – | 1,604,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
| Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
| Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
| Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
| Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
| Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
| Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
| Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
| Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |